The Pennant Group, Inc.
NASDAQ:PNTGMedical - Care Facilities
-$0.83 today
- Market cap
- $1.26B
- Beta
- 1.27
- P/E (TTM)
- 38.6
- EPS (TTM)
- $0.87
Volume 0.43M
Average 0.25M
PNTG Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
The Pennant Group, Inc.NASDAQ: PNTG
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables declines year over year
Q1 FY2026 accounts receivables of $35K (cash outflow) fell 99.7% year over year, behind the -57.9% change in trailing-twelve-month accounts receivables. Sequentially, it fell 99.6% from the prior quarter. Over 3 fiscal years it compounded at +305.9% a year.
Context
- Accounts receivables amounted to 2.5% of revenue in FY2025, down 0.5 pp from a year earlier.
- Accounts receivables grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -99.7% toward the trailing-twelve-month pace of -57.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (24.15M) USD
- Year-over-year change
- -14.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (24.15M) | -14.5% |
| FY2024 | 2024-12-31 | (21.09M) | -186.9% |
| FY2023 | 2023-12-31 | (7.35M) | -1936.0% |
| FY2022 | 2022-12-31 | (361K) | +95.1% |
| FY2021 | 2021-12-31 | (7.34M) | — |
Accounts Receivables vs competitors
How PNTG compares with its peers on the latest reported figures
- PNTG's LTM Mar 2026 accounts receivables of $10.3M is the 6th largest of the 11 companies compared; the peer median is $6.08M.
- Its year-over-year change of -57.9% is the 9th highest of 11, against a peer median of +182.1%.
- Accounts receivables amounts to 1.0% of revenue for PNTG, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $91.03M | +197.4% | -5.1% | 1.7% | |
| LTM Jun 2026 | $62.9M | +362.5% | -3.5% | 1.0% | |
| LTM Jun 2026 | $18.69M | -68.5% | — | 0.3% | |
| LTM Oct 2026 | $16.53M | +166.8% | +110.8% | 0.6% | |
| LTM Sep 2026 | $14.92M | +202.5% | +50.6% | 0.5% | |
| LTM Mar 2026 | $10.3M | -57.9% | +305.9% | 1.0% | |
| LTM Jun 2026 | $9.98M | -1289.6% | — | 0.7% | |
| LTM Sep 2026 | $8.96M | +344.5% | -1.6% | 0.6% | |
| LTM Mar 2026 | $7.32M | -18.8% | +8.1% | 1.8% | |
| LTM Jun 2026 | $4.85M | +1224.0% | +68.7% | 0.2% | |
| LTM Mar 2026 | $4.32M | +141.8% | — | 0.5% | |
| Peer median (excluding PNTG) | $6.08M | +182.1% | +8.1% | 0.6% | |
Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.15M | 7.24M | 13.91M | 24.34M | 33.76M |
| Depreciation & Amortization | 4.78M | 4.9M | 5.13M | 6.12M | 8.54M |
| Deferred Income Tax | (1.75M) | 1.7M | 4M | (1.19M) | (2.19M) |
| Stock-Based Compensation | 10.04M | 3.09M | 5.37M | 7.78M | 8.94M |
| Change in Working Capital | (37.38M) | (9.5M) | 3.44M | 929K | (1.6M) |
| Accounts Receivables | (7.34M) | (361K) | (7.35M) | (21.09M) | (24.15M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 562K | 2.37M | (1.85M) | 8.05M | 5.8M |
| Other Working Capital | (30.61M) | (11.51M) | 12.64M | 13.97M | 16.75M |
| Other Non-Cash Items | 3.94M | 1.62M | 1.24M | 1.32M | 837K |
| Operating Cash Flow | (18.22M) | 9.04M | 33.09M | 39.3M | 48.29M |
| Capital Expenditures | (6.3M) | (14.17M) | (8.11M) | (8.99M) | (22M) |
| Acquisitions (Net) | (13.55M) | (10.13M) | (21.38M) | (48.42M) | (204.02M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | (2.89M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (267K) | 61K | (741K) | (13.28M) | 943K |
| Investing Cash Flow | (20.12M) | (24.24M) | (30.22M) | (70.68M) | (227.97M) |
| Debt Repayment | 44M | 11M | 500K | (65M) | 173.8M |
| Common Stock Issued | 0 | 1.08M | 579K | 119M | 552K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (510K) | 1.08M | 33K | (4.43M) | (1.89M) |
| Financing Cash Flow | 43.49M | 12.08M | 1.11M | 49.57M | 172.46M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 5.15M | (3.11M) | 3.98M | 18.19M | (7.22M) |
| Free Cash Flow | (24.53M) | (5.13M) | 24.99M | 30.31M | 26.3M |
The Pennant Group, Inc.
NASDAQ:PNTG
Intrinsic Alpha fair value
Locked
Current Price
$35.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.